SoylentNews
SoylentNews is people
https://soylentnews.org/

upstart writes:

Submitted via IRC for SoyCow1984

Drug companies are sitting on generics—43% of recently approved aren't for sale

Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.

The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.

Original Submission

1. "upstart" - https://soylentnews.org/~upstart/
2. "Drug companies are sitting on generics—43% of recently approved aren't for sale" - https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/
3. "more than 700—or 43 percent—are not for sale" - https://khn.org/news/trump-administration-salutes-parade-of-generic-drug-approvals-but-hundreds-arent-for-sale/
4. "Original Submission" - https://soylentnews.org/submit.pl?op=viewsub&subid=31685

printed from SoylentNews, Drug Companies are Sitting on Generics—43% of Recently Approved Aren’t for Sale on 2024-04-23 22:07:51